Your browser version may not work well with NCBI's Web applications. More information here...
1: J Invasive Cardiol. 2007 Mar;19(3):142-4.Links

Preliminary experiences closing secundum atrial septal defect using the modified Cardia Intrasept device.

Chessa M, Butera G, Carminati M.

Pediatric Cardiology and Adults with Congenital Heart Disease, IRCCS--Policlinico San Donato, San Donato, Milan, Italy. massimo.chessa@grupposandonato.it

During the past decade, transcatheter occlusion of secundum atrial septal defects (Type II ASDs) has become a widely accepted alternative to surgical closure. To date, over 6,000 patients have been treated with the Cardia Intrasept PFO occluder (Cardia Inc., Burnsville, Minnesota) for the percutaneous closure of patent foramen ovale (PFO). This is a report of the use of a modified Intrasept device to close Type II ASDs in 4 patients.

PMID: 17341783 [PubMed - indexed for MEDLINE]